From: Lipidomic profile and candidate biomarkers in septic patients
Study | Methods | Participants | Interventions | Results |
---|---|---|---|---|
Drobnik et al., 2003 [37] | Prospective Experimental | 102 patients with sepsis and 56 control | Analyses by mass spectrometry. The samples were collected as soon as sepsis criteria were met and mortality analyzed at 30 days. | Most Cer species were increased in sepsis patients, while all LPC species were markedly decreased. Species-specific as well as total Cer-SPM ratios were increased, whereas LPC-PC ratios were decreased in sepsis patients. The increased Cer-SPM ratios as well as the decreased LPC-PC ratios showed a strong predictive power for sepsis-related mortality. Total cholesterol, HDL-C, and LDL-C in sepsis patients were markedly reduced compared with a healthy population. |
Cho et al., 2012 [59] | Prospective Not randomized | Patients meeting sepsis criteria (105) and control – healthy blood donors (21) | Blood samples collected on the first day. Samples were analyzed using the ANZWELL LPC Assay commercial kit (Alfresa Pharma Corporation, Osaka, Japan). | Mean of serum concentration of LPC was significantly lower in patients with sepsis than in healthy individuals. No differences were observed between survivors and non-survivors in septic patients. |
Schmerler et al., 2012 [69] | Prospective Not randomized | 161 patients (74 with SIRS, 69 with sepsis and 18 control – patients in ICU without SIRS) | Samples of blood samples were collected within the first 24 h of admission of patients with SIRS. For patients with sepsis, samples were collected at 24 h after the onset of organ dysfunction. Analyzes were performed by mass spectrometry. | Acylcarnitine (C10:1) and Phosphatidylcholine (PCaaC32:0) were significantly higher in patients with sepsis compared to patients with non-infectious SIRS. |
Cho et al., 2014 [65] | Prospective Not randomized | A total of 56 patients with community-acquired pneumonia (CAP) | Blood samples were collected from patients with CAP on days 1 and 7 and analyzed for their plasma LPC concentrations. Blood samples were analyzed using an Anzwell LPC Assay Kit commercial (Alfresa Pharma, Osaka, Japan). | 24 (42.9%) of patients required intubation and 15 (26.8%) died. The mean LPC concentrations on days 1 and 7 were significantly lower in the non-survivors. LPC levels < 29.6 μmol/L at day 1 were associated with outcomes such as the need for mechanical ventilation, vasopressors, ICU admission and hospital mortality. |
Park et al., 2014 [67] | Prospective, observational | A total of 74 patients with confirmed diagnosis of infection with at least two criteria of SIRS, within 24 h of admission in ICU | Blood sample analyzed on day 1 and day 7. Blood samples were analyzed using an Anzwell LPC Assay Kit commercial (Alfresa Pharma, Osaka, Japan). | The LPC concentration on day 7 was significantly lower in non-survivors. A decreased LPC concentration on day 7 and sustained high concentration of procalcitonin on day 7 were related to 28-day mortality. LPC concentrations increased over time in patients with appropriate antibiotics. |
Liang et al., 2016 [70] | Prospective | ICU patients with sepsis induced lung injury - SLI (80) and healthy volunteers (82) | Plasma samples were collected in the morning at ICU with 10 h of fasting and analyzed by chromatography/mass spectrometry. | Significant changes were found in 7 metabolites, with an increase in concentration in SLI patients in 5 of them and a decrease in 2. Lipid metabolites include PE (P-19: 1 (12Z) / 0: 0), PE (22: 2 13Z, 16Z) / 15: 0), PC (17: 0/0: 0), LPC (P-16: 0), PE (20: 3 (8Z, 11Z, 14Z) / 0: 16: 0/0: 0) and PC (17: 1 (10Z) / 0: 0). PE (P-19: 1 (12Z) / 0: 0) showed sensitivity of 98.1% and specificity of 97.3%. Three lipids (PE (P-19: 1 (12Z) / 0: 0), PE (22: 2 (13Z, 16Z) / 15: 0), PC (17: 0/0: 0)) were selected to form a group of biomarkers to improve risk discrimination among SIL patients and healthy cases. |
Ferrario et al., 2016 [64] | Retrospective | Plasma of 20 patients with severe septic shock (SOFA score > 8) enrolled in a multicenter Study (Albumin Italian Outcome Sepsis Study) | Plasma samples were analyzed by spectrometry that included quantitative measurements of acylcarnitines, aminoacids, biogenicamines, glycerophospholipids, sphingolipids, and sugars. | Unsaturated long-chain phosphatidylcholines and LPC species were associated to the event at 28-days and 90-days in combination with clinical variables such as cardiovascular SOFA score (28-day mortality model) or renal replacement therapy (90-day mortality model). |
Mecatti et al., 2018 [39] | Prospective Not randomized | Septic patients (n = 20) and healthy controls (n = 20) | Samples were collected in the first 36 h of admission to the ICU and analyzed by gas chromatography and mass spectrometry. | LPCs and SMs were downregulated, whereas the saturated and unsaturated phosphatidylcholines (PCs) were upregulated in the plasma and erythrocytes of septic patients. |
Park et al., 2019 [61] | Prospective Controlled | Patients with severe sepsis and septic shock (n = 143), with pneumonia (n = 12), and healthy individuals (n = 31) | Quantitative analyses of LPC 16:0 were performed in samples of sera using a matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry on a parylene-matrix chip. | Sensitivity of 97.9% and selectivity of 95.5% in sepsis diagnosis as compared to healthy individuals and patients with pneumonia. |
Ferrario et al., 2019 [42] | Experimental Controlled | Swine model (n = 9) | Induced peritonitis was performed in a swine model, and changes in hemodynamic, blood chemistry, and inflammatory markers were monitored. Quantitative mass spectrometry-based targeted metabolomic analyses were performed. | Marked decrease in phosphatidylcholines and LPC species, altered alanine-glucose cycle and inter-organ amino acid metabolism. |
Arshad et al., 2019 [66] | Prospective Controlled | Patients with community-acquired pneumonia (n = 29) and with chronic obstructive pulmonary disease exacerbation with infection (n = 13) and control group (n = 33) | 105 phospholipids, 40 acylcarnitines, and 4 ceramides, as well as acid sphingomyelinase activity were analysed in plasma using a triple-quadrupole mass spectrometer. | Phospholipid concentrations were greatly decreased in community-acquired pneumonia and normalized in the course of clinical improvement. The changes in COPD were less pronounced, but also differed qualitatively. |